CorVel Corporation
At today's price, CorVel Corporation (CRVL) is priced for +10.3% earnings growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• CorVel sells cost containment for workers' compensation and healthcare claims: it sits between the payer and the bill, using its CareMC platform and CERIS payment-integrity service to take cost out of claims, and it does this earning a return on equity around 28%. • The defining number is the multiple: at roughly 27 times earnings the price assumes CorVel keeps compounding fee earnings near 9% a year, a pace it has delivered but that leaves little room for a stumble. • What to watch is the CER
Is CRVL overvalued? See what's priced in →
269 institutional managers reported holding CRVL in 13F filings for the quarter ended 2026-03-31. Together they hold about 52% of the company; the top 10 hold 38%. 33 opened new positions that quarter. Held by BlackRock, Vanguard Group, Renaissance Technologies, among others. On the short side, 1.2M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (5.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CRVL has cut its share count 4.4% over the past five years, spending $309.08M on repurchases. It pays no dividend. Cash returned over the past three years: $121.73M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at CRVL over the trailing three years. Absence is a fact about the company, not a signal. 11 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CRVL's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | +5.9% | -5.1% |
| 2023-11-03 | +3.0% | +16.0% |
| 2024-02-02 | +1.7% | +0.9% |
| 2024-05-25 | -0.3% | +11.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CRVL's latest 8-K filings: 2026-06-01 (items 5.02, 7.01, 9.01); 2026-05-20 (items 2.02, 9.01); 2026-02-03 (items 2.02, 9.01); 2025-11-04 (items 2.02, 9.01); 2025-09-12 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 18, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.